Swiss National Bank Teva Pharmaceutical Industries LTD Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Swiss National Bank holds 3,342,900 shares of TEVA stock, worth $58.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,342,900

Previous 3,327,600 0.46%

Holding current value

$58.5 Million

Previous $54.1 Million 11.4%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$15.81 - $18.96 $241,893 - $290,088	15,300 Added 0.46%	3,342,900 $60.2 Million
Q2 2024 Aug 08, 2024	SELL	$12.78 - $17.4 $219,816 - $299,280	-17,200 Reduced 0.51%	3,327,600 $54.1 Million
Q1 2024 May 07, 2024	SELL	$10.67 - $14.43 $1.67 Million - $2.26 Million	-156,900 Reduced 4.48%	3,344,800 $47.2 Million
Q4 2023 Feb 06, 2024	SELL	$8.12 - $10.63 $991,451 - $1.3 Million	-122,100 Reduced 3.37%	3,501,700 $36.6 Million
Q3 2023 Nov 08, 2023	SELL	$7.48 - $10.7 $2.7 Million - $3.86 Million	-360,500 Reduced 9.05%	3,623,800 $37 Million
Q2 2023 Aug 09, 2023	SELL	$7.2 - $9.47 $3 Million - $3.95 Million	-417,100 Reduced 9.48%	3,984,300 $30 Million
Q1 2023 May 10, 2023	SELL	$8.36 - $11.37 $907,895 - $1.23 Million	-108,600 Reduced 2.41%	4,401,400 $39 Million
Q4 2022 Feb 08, 2023	SELL	$7.95 - $9.48 $1.64 Million - $1.95 Million	-206,093 Reduced 4.37%	4,510,000 $41.1 Million
Q3 2022 Nov 09, 2022	BUY	$6.86 - $11.95 $190,022 - $331,015	27,700 Added 0.59%	4,716,093 $38.1 Million
Q2 2022 Aug 09, 2022	BUY	$7.38 - $10.4 $233,946 - $329,680	31,700 Added 0.68%	4,688,393 $35.3 Million
Q1 2022 May 09, 2022	BUY	$7.33 - $9.39 $2.59 Million - $3.32 Million	353,300 Added 8.21%	4,656,693 $43.7 Million
Q4 2021 Feb 08, 2022	SELL	$7.9 - $10.19 $1.97 Million - $2.55 Million	-249,900 Reduced 5.49%	4,303,393 $34.5 Million
Q3 2021 Nov 08, 2021	SELL	$8.38 - $10.18 $963,700 - $1.17 Million	-115,000 Reduced 2.46%	4,553,293 $44.3 Million
Q2 2021 Aug 06, 2021	BUY	$9.9 - $11.56 $3.44 Million - $4.02 Million	347,894 Added 8.05%	4,668,293 $46.2 Million
Q1 2021 May 07, 2021	BUY	$10.34 - $12.81 $1.01 Million - $1.26 Million	98,100 Added 2.32%	4,320,399 $49.9 Million
Q4 2020 Feb 05, 2021	SELL	$8.61 - $11.04 $880,803 - $1.13 Million	-102,300 Reduced 2.37%	4,222,299 $40.7 Million
Q3 2020 Nov 09, 2020	SELL	$8.57 - $12.69 $663,318 - $982,206	-77,400 Reduced 1.76%	4,324,599 $39 Million
Q2 2020 Aug 05, 2020	BUY	$8.12 - $13.12 $767,339 - $1.24 Million	94,500 Added 2.19%	4,401,999 $54.3 Million
Q1 2020 May 08, 2020	BUY	$6.69 - $13.45 $3.25 Million - $6.54 Million	486,000 Added 12.72%	4,307,499 $38.7 Million
Q4 2019 Feb 06, 2020	SELL	$6.53 - $10.72 $1.36 Million - $2.23 Million	-207,600 Reduced 5.15%	3,821,499 $37.5 Million
Q3 2019 Nov 12, 2019	BUY	$6.16 - $9.6 $271,040 - $422,400	44,000 Added 1.1%	4,029,099 $27.7 Million
Q2 2019 Aug 02, 2019	BUY	$8.12 - $15.72 $3.36 Million - $6.5 Million	413,800 Added 11.59%	3,985,099 $36.8 Million
Q1 2019 May 10, 2019	BUY	$15.58 - $20.01 $579,576 - $744,372	37,200 Added 1.05%	3,571,299 $56 Million
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $456,667 - $746,192	31,300 Added 0.89%	3,534,099 $54.5 Million
Q3 2018 Nov 08, 2018	SELL	$21.06 - $25.65 $3.88 Million - $4.72 Million	-184,100 Reduced 4.99%	3,502,799 $75.5 Million
Q2 2018 Aug 09, 2018	BUY	$16.77 - $24.71 $5.01 Million - $7.38 Million	298,600 Added 8.81%	3,686,899 $89.7 Million
Q1 2018 May 04, 2018	SELL	$16.68 - $22.07 $2.26 Million - $2.98 Million	-135,200 Reduced 3.84%	3,388,299 $57.9 Million
Q4 2017 Feb 07, 2018	BUY	$11.23 - $19.1 $359,360 - $611,200	32,000 Added 0.92%	3,523,499 $66.8 Million
Q3 2017 Nov 03, 2017	BUY	$15.41 - $32.17 $53.8 Million - $112 Million	3,491,499	3,491,499 $61.5 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Teva Pharmaceutical Industries LTD Transaction History